Engineering Thrombin for Selective Specificity toward Protein C and PAR1
Authors:
- Leslie A. PelcLPLeslie A. Pelc
- Austin VogtAVAustin Vogt
- Prafull S. GandhiPGPrafull S. Gandhi
- Enrico Di CeraECEnrico Di Cera
Open Access
- 1 June 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (25) , 19145-19152
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Thrombin Mutant W215A/E217A Acts as a Platelet GPIb AntagonistArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Molecular Dissection of Na+ Binding to ThrombinJournal of Biological Chemistry, 2004
- Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis.2004
- Residue Asp-189 Controls both Substrate Binding and the Monovalent Cation Specificity of ThrombinJournal of Biological Chemistry, 2004
- Redesigning the monovalent cation specificity of an enzymeProceedings of the National Academy of Sciences, 2003
- Thrombin and Platelet ActivationChest, 2003
- Serine Protease Mechanism and SpecificityChemical Reviews, 2002
- Ser214 Is Crucial for Substrate Binding to Serine ProteasesJournal of Biological Chemistry, 2002
- Activated protein C: Potential therapy for severe sepsis, thrombosis, and strokeSeminars in Hematology, 2002
- Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C PathwayScience, 2002